Portage Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019	2018	2017
Net Income	-104.67	-19.17	-17.19	-7.25	-3.59	123.74
Depreciation & Amortization	0	0	0	0	0	0
Share-Based Compensation	4.28	9.14	8.83	2.16	1.17	1.13
Other Operating Activities	88.32	3.26	4.08	1.38	1.57	-125.94
Operating Cash Flow	-12.07	-6.76	-4.28	-3.71	-0.86	-1.07
Capital Expenditures	-0	0	0	0	0	0
Acquisitions	0	0	-1	0	-0.45	-1.63
Change in Investments	-0.61	0	0.14	0	0	7.29
Investing Cash Flow	-0.62	0	-0.86	0	-0.45	5.66
Share Issuance / Repurchase	2.98	29.2	6.98	0	0	2.73
Debt Issued / Paid	-3.01	0	-1.97	0.7	-0.05	0.05
Other Financing Activities	-0.09	-1.85	-0.25	-	-	-
Financing Cash Flow	-0.12	27.35	4.76	0.7	-0.05	2.78
Net Cash Flow	-12.81	20.58	-0.38	-3.01	-1.35	7.36
Free Cash Flow	-12.08	-6.76	-4.28	-3.71	-0.86	-1.07
Free Cash Flow Per Share	-0.75	-0.52	-0.36	-0.34	-0.18	-0.40

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).